APA (7th ed.) Citation

Baltruškevičienė, E. (2016). Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: A single institution experience. Vilniaus Universitetas.

Chicago Style (17th ed.) Citation

Baltruškevičienė, Edita. Significance of KRAS, NRAS, BRAF and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Receiving Bevacizumab: A single Institution Experience. Vilniaus Universitetas, 2016.

MLA (9th ed.) Citation

Baltruškevičienė, Edita. Significance of KRAS, NRAS, BRAF and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Receiving Bevacizumab: A single Institution Experience. Vilniaus Universitetas, 2016.

Warning: These citations may not always be 100% accurate.